MedTrace Logo

Kineret CAPS Post Authorisation Study

NCT02326376 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2020-01-18

No results posted yet for this study

Summary

A non-interventional, post authorization safety study to evaluate the safety of Kineret in the treatment of Cryopyrin Associated Periodic Syndromes (CAPS) in routine clinical care with regard to serious infections, malignancies, injection site reactions, allergic reactions and medication errors, including re-use of syringe.

Conditions

  • Cryopyrin-Associated Periodic Syndromes

Interventions

DRUG

anakinra (Kineret)

Sponsors & Collaborators

  • Pediatric Rheumatology International Trials Organization

    collaborator OTHER

  • Swedish Orphan Biovitrum

    lead INDUSTRY

Principal Investigators

  • Marco Gattorno, MD · IRCCS Istituto Giannina Gaslini

  • Torbjörn Kullenberg, MD · Swedish Orphan Biovitrum AB (publ)

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-24
Primary Completion
2019-09-12
Completion
2019-09-12

Countries

  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02326376 on ClinicalTrials.gov